Detalhe da pesquisa
1.
Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial.
Cancer Immunol Immunother
; 71(8): 1897-1908, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984540
2.
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Lancet Oncol
; 21(6): 832-842, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416073
3.
Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer.
Toxicol Appl Pharmacol
; 379: 114662, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301315
4.
Degradation of Mcl-1 through GSK-3ß Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
Cell Physiol Biochem
; 41(5): 2067-2076, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419994
5.
RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.
Cell Physiol Biochem
; 35(1): 237-45, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25591766
6.
PSMA7 directly interacts with NOD1 and regulates its function.
Cell Physiol Biochem
; 31(6): 952-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23839082
7.
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma.
Cancer Biol Med
; 2022 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014769
8.
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Cancer Cell
; 40(3): 277-288.e3, 2022 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245446
9.
Blocking C-Raf alleviated high-dose small-volume radiation-induced epithelial mesenchymal transition in mice lung.
Sci Rep
; 10(1): 11158, 2020 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32636458
10.
Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.
Ann Transl Med
; 8(10): 660, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32566597
11.
Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.
Ann Transl Med
; 7(18): 482, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31700918
12.
Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer.
Chin J Integr Med
; 14(1): 33-6, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18219455
13.
Radiosensitivity enhancement by arsenic trioxide in conjunction with hyperthermia in the EC-1 esophageal carcinoma cell line.
Asian Pac J Cancer Prev
; 13(4): 1693-7, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22799390
14.
Antitumor activity of a combination of rAd2p53 adenoviral gene therapy and radiotherapy in esophageal carcinoma.
Cell Biochem Biophys
; 59(3): 147-52, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350839